Tao et al.42identified that FTO acts as a biomarker for the diagnosis or prognosis of bladder cancer and promotes the tumorigenesis of bladder cancer via regulating the m6A level of MALAT. The gene discussed is FTO; the disease is urinary bladder carcinoma.